The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Industry Session

IS1-8

Targeting BCL2 to treat hematological cancers

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Harumi Mukai (Hepatology & Oncology, Medical Affairs, Medical, AbbVie GK)

Sponsor: AbbVie GK

[IS1-8] Targeting BCL2 to treat hematological cancers

David Huang (Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia)